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A B S T R A C T
Aptamers are short single-stranded nucleic acid sequences capable of binding to target molecules in a way
similar to antibodies. Due to various advantages such as prolonged shelf life, low batch to batch variation, low/
no immunogenicity, freedom to incorporate chemical modification for enhanced stability and targeting capacity,
aptamers quickly found their potential in diverse applications ranging from therapy, drug delivery, diagnosis,
and functional genomics to bio-sensing. Aptamers are generated by a process called SELEX. However, the current
overall success rate of SELEX is far from being satisfactory, and still presents a major obstacle for aptamer-based
research and application. The need for an efficient selection strategy consisting of defined procedures to deal
with a wide variety of targets is significantly important. In this work, by analyzing key aspects of SELEX in-
cluding initial library design, target preparation, PCR optimization, and single strand DNA separation, we
provide a comprehensive analysis of individual steps to facilitate researchers intending to develop personalized
protocols to address many of the obstacles in SELEX. In addition, this review provides suggestions and opinions
for future aptamer development procedures to address the concerns on key SELEX steps, and post-SELEX
modifications.
1. Introduction
First introduced in 1990 (Ellington and Szostak, 1990; Tuerk and
Gold, 1990), aptamers are short synthetic single-stranded (ss) nucleic
acid sequences that can bind to a broad range of targets including metal
ions, chemical compounds, proteins, cells and whole micro-organisms.
As a class of affinity ligands, aptamers display some advantages over
traditional antibodies such as prolonged shelf life, low batch to batch
variation, low/no immunogenicity, and the flexibility to incorporate
chemical modifications for enhanced stability and targeting affinity
(Wang et al., 2015). Consequently, over the past few decades, aptamers
quickly found their way in diverse applications ranging from therapy,
drug delivery, diagnosis, and functional genomics to bio-sensing
(AlShamaileh et al., 2017; Khan et al., 2018; Shigdar et al., 2013a;
Tapsin et al., 2018).
Aptamers are generally developed in vitro by a very defined iterative
procedure known as Systematic Evolution of Ligands by Exponential
enrichment (SELEX) (Tuerk and Gold, 1990). The originally reported
SELEX procedures is, however, time and labor consuming. Over the past
three decades, by adaption and integration of progresses in material
sciences and analytical techniques, various SELEX variations have been
reported in an attempt to either reduce processing time (e.g. CE-SELEX
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(Yang and Bowser, 2013), Flu-Mag SELEX (Stoltenburg et al., 2005), in
silico SELEX (Rabal et al., 2016)), generate aptamers with novel designs
and functions (e.g. μFFE-SELEX (Jing and Bowser, 2011), Capture-
SELEX (Istamboulie et al., 2017)), or increase the process throughput
(e.g. Sweep-CE-SELEX (Okhonin et al., 2004)). Today, some groups can
reduce the time for aptamer development from months required for
conventional SELEX to several hours (Lokesh et al., 2017; Martin et al.,
2015; Zhuo et al., 2017). Furthermore, a recently developed computer
supported in silico assay promises to predict an aptamer structure even
before SELEX is conducted (Ahirwar et al., 2016). Stemming from this,
aptamers such as the hydrophobic SOMAmers (Eid et al., 2015),
thioaptamers (Volk and Lokesh, 2017), and X-Aptamers (Lokesh et al.,
2017) have been developed. NOX-A12, a nuclease resistant L-nucleic
acid aptamer (Vater and Klussmann, 2015), recently entered Phase 1/2
clinical trial for multiple oncology indications (ClinicalTrials.gov
Identifier: NCT03168139). Progress in nucleic acid chemistry and se-
lection strategies significantly contribute to the commercialization and
clinical translation of aptamers. However, it is worth mentioning that
the number of aptamers showing strong binding capacity and specificity
is still limited (Baird, 2010). Improving the current SELEX procedure
and developing more aptamers with high binding capacity and speci-
ficity remains a major hurdle for aptamer related basic and applied
studies, and the knowledge accumulated over the last three decades
would be of significant benefit in developing the successful individual
SELEX procedure.
SELEX is a typical multidisciplinary procedure related to different
fields such as molecular biology, nucleic acid chemistry, material sci-
ence, and bioinformatics to develop affinity ligands against a vast
variety of targets (Blind and Blank, 2015). As such, a standard SELEX
protocol suitable for all experimental settings may not exist (Svobodova
et al., 2012). To identify aptamers for a specific target, one needs to
design a SELEX protocol with various factors in consideration such as
time- and cost-efficiency of the chosen SELEX protocol, type and
modification of initial libraries, accessibility to instruments etc. Indeed,
to manipulate the art of SELEX, it is necessary to comprehensively study
each of the key steps of SELEX (Fig. 1) and associated techniques. Re-
cent SELEX review articles generally provide readers with an overview
of SELEX strategies or aptamer related applications, in most cases, de-
tailed illustration and comparison of key techniques of SELEX varia-
tions are overlooked. In this review, instead of describing individual
SELEX procedures, by focusing on key steps of SELEX, and via critical
discussion and analysis of knowledge and lessons collected during the
past three decades, we evaluate the current SELEX strategies and pro-
vide an insight on promising SELEX associated techniques to broad
researchers intending to develop tailored SELEX protocols for different
application settings. In addition, current strategies for post-SELEX
modifications are also discussed.
2. SELEX library design
The initial nucleic acid (NA) library provides a crucial starting point
for SELEX. Herein, we summarize and discuss the fundamental aspects
of NA library design such as the type of library, the primer binding site,
chemical modification, the presence of fixed sequences, and randomi-
zation strategies, to present a comprehensive picture of SELEX library
design.
2.1. DNA or RNA?
Native DNA and RNA based libraries are used in majority of the
currently performed SELEX procedures, although the use of artificial
nucleic acids (see Section 2.3.3.2) has also been emerged as a tool for
aptamer development with improved properties (Sefah et al., 2014).
Despite the fact that a DNA library had been successfully employed for
SELEX since very early stages of aptamer development (Ellington and
Szostak, 1992), RNA libraries were preferentially used in the majority
of the early SELEX protocols - based on the belief that RNA could fold
into more functional motifs and result in higher affinity binders (Cheng
et al., 2001). However, accumulating evidences suggest that ssDNA
exhibits comparable propensity for forming intricate tertiary structures
with that of RNA. This finding is important for aptamer related work.
Evidently, in terms of aptamer development and subsequent applica-
tion, DNA aptamers show advantages over their RNA counterparts
(Lakhin et al., 2013). Firstly, DNA is more chemically and biologically
stable, which makes both selection and application easier. This is
especially true when microarray platforms are applied for high
throughput SELEX; secondly, DNA-based SELEX is more cost and time-
effective, as an extra reverse transcription step essential for RNA SELEX
is not required; thirdly, from the perspective of commercialization,
DNA is easier to synthesize and is more robust than RNA in terms of
shelf life (Lakhin et al., 2013). Accordingly, DNA libraries are being
used more frequently in recent SELEX studies. By 2007, DNA re-
presented half of the performed SELEX libraries. And more than 85% of
the reported aptamers in 2013 were developed using DNA. Today, DNA
aptamers represent almost all of the products provided by commercial
aptamer developers (Darmostuk et al., 2015). As a special variation of
SELEX, genomic SELEX is very different from common SELEX by em-
ploying genomic DNA (double strand), genome encoded RNA, and
transcriptomic total RNA as starting libraries (Cheung et al., 2013).
Genomic SELEX is mainly for functional studies aiming to identify
regulatory domains in a genome such as DNA sequences recognized by
transcription factors, RNA fragments recognized by splicing factors,
RNA polymerases, ribosomes or other components of the gene expres-
sion machinery (Vorobyeva et al., 2018). Since RNA especially non-
coding RNA plays an important role in gene regulation, RNA represents
the majority of the libraries used in genomic SELEX (Cheung et al.,
2013). A critical feature of a genome library is the restricted sequence
information. As reported, the human genome encodes 3x109 bp with a
plethora of redundant and repeat sequences (Hood and Rowen, 2013).
As a result, a typical genomic SELEX library displays substantially lower
sequence diversity as compared with randomized NA libraries (108
times lower than a standard SELEX library with 40 nt random se-
quences). Although low sequence diversity is problematic for normal
SELEX, it presents an advantage for genomic SELEX. This is because the
binding sequences are endogenously included in the pool, a dramatic
decrease in the diversity of the starting library would favor the suc-
cessful identification of targets.
2.2. Constant region of SELEX libraries
2.2.1. Primer binding sites
2.2.1.1. How primer-binding sites affect the SELEX process. A classic
SELEX library contains a randomized region, flanked by two fixed
primer-binding sequences on both ends to enable amplification of the
enriched sequences via PCR (Fig.2) (Wu and Kwon, 2016). This type of
library format has been used in most published SELEX studies. Ideally,
the developed aptamer sequences should bind their targets through
tertiary structures formed only by nucleotides from the random region.
However, during the SELEX procedure, the interaction between the
constant primer binding sites and sequences in the random region is
inevitable (Tolle et al., 2014). Previous studies confirmed this
phenomenon where the primer-binding sites participate in the
functional secondary structures of developed aptamers (Shui et al.,
2012). Considering the significant number of primer binding sites in a
SELEX library, they would critically influence which aptamers are
selected from the random pool. This is because, theoretically, functional
motifs whose structure exploit the constant primer binding regions may
be more prevalent in the enriched pool and predominate during the
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selection process. Following this logic, primer-binding sites would
engage in many of the developed aptamers and cannot be simply cut
off to minimize the length of the sequence during aptamer truncation
and additional minimization studies.
However, according to an analysis of> 2000 sequences from the
Aptamer Database, although a number of outliers exist, for the majority
of aptamers, their folding secondary structure was independent of the
flanking primer-binding sequences. In other words, such constant re-
gions do not seem to participate in aptamer binding structures
(Cowperthwaite and Ellington, 2008). One explanation is that, in a
certain NA library, the functional sequences and structures for target
binding will only rarely require the arbitrary sequence provided by a
constant primer-binding region (Cowperthwaite and Ellington, 2008).
The structures formed by random region alone should be much more
complex than structures created by the interaction between primer-
binding sites and random sequences (Cowperthwaite and Ellington,
2008). However, this statement does have drawbacks. Firstly, although
for an individual sequence the chance of creating an information-rich
structure by the interaction between the primer-binding site and the
internal random sequence is low, considering the large amount of such
constant sequences in a given pool, the contribution of constant primer
binding sites to the creation of information-rich structures is hard to
estimate. Secondly, there is accumulating evidence indicating that pre-
designed constant sequences could significantly improve the binding
propensity of SELEX libraries – suggesting the effect of the constant
region in a SELEX library should not be disregarded. Another
Fig. 1. An illustration of the key steps of a typical
SELEX protocol. SELEX is a comprehensive proce-
dure consisting of a very defined iterative procedure.
A typical SELEX procedure includes library design,
target preparation, counter selection, positive selec-
tion, bound/unbound sequence separation, reverse
transcription (for RNA aptamer), PCR amplification,
single strand DNA separation (for DNA aptamer) and
transcription (for RNA aptamer).
Fig. 2. The interaction between primer binding sites
and random sequences of SELEX library causes PCR
bias and affects the progress of SELEX. (A) Sequences
with the random region displaying interaction with
the primer binding sites (sequence a and b) show a
selective disadvantage for primer binding and sub-
sequent PCR amplification. (B) Even with identical
binding capacity to targets, sequences displaying
PCR disadvantage with random region displaying
interaction with the primer binding sites (compete
for the binding of primers to primer binding sites as
shown in b and c) are gradually eliminated from the
library pool with the progress of SELEX.
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explanation claims that the primer-binding sites may only be able to
participate in a limited number of structural motifs because they are
located at the end of the library sequences (Cowperthwaite and
Ellington, 2008). However, there is no evidence to support this ex-
planation, hence the effect of the 5'- and 3'-end locations of constant
regions and their interaction with the random region of libraries need to
be further studied.
The observed negligible participation of primer-binding sites on
aptamer structures is more likely resulting from the evolution process of
SELEX (Fig. 2). As an essential part of SELEX, PCR amplification starts
by the binding of primers to the constant primer binding sites. Se-
quences with the random region displaying strong interaction with the
constant primer binding sites (compete for the binding of primer to
primer binding sites) may show a selective disadvantage for primer
binding and subsequent amplification (Coleman and Huang, 2005).
Over multiple rounds of selection and amplification, this selection
disadvantage is likely to surpass any selective advantages of functional
motifs formed by the random regions (Fig. 2). In contrast, sequences
with the random region that do not display interactions with the con-
stant primer binding sites (Fig. 2Ac) are more likely to dominate the
PCR product pool due to their adaptation to the PCR program (does not
affect primer and primer-binding site recognition) (Coleman and
Huang, 2005). Based on this explanation, the selected aptamers actively
avoid interference with the primer-binding site. The fact that primer
binding site does not present prominently in overall aptamer structures
and that it is impossible to adequately predict the interaction between
primer binding sites and random regions in a library (including up to
1015 sequences species) make the design of primer binding site of li-
brary pools simplified. Theoretically, any primer sequences that are
generally suitable for PCR would be appropriate for SELEX screenings.
2.2.1.2. Minimizing primer-binding sites. The absence of primer binding
sites on selected aptamers does not mean these sites do not affect the
SELEX process. As shown in Fig. 2, it can detrimentally affect aptamer
selection by reducing the number of functional motifs encoded in
random regions. Strategies have been made to minimize the
detrimental effect caused by primer-binding sites. Optimization of the
length of the random region represents the mostly employed approach.
Theoretically, with four natural bases, the maximum number of
available spaces in a given library can be reached by random regions
with a length of 28 nt (Pobanz and Luptak, 2016). And libraries with
random sequence as short as 15 nt had been successfully used in a
previous study (Kupakuwana et al., 2011). Indeed, utilizing short
aptamer libraries has various advantages including (1) the
convenience and low cost of its chemical synthesis; (2) the reduced
possibility of PCR by-products formation; and (3) facilitate subsequent
sequence truncation and applications. However, as demonstrated by a
comparative study using a variety of pool lengths, aptamers selected
from libraries with short random sequence pools relied much more
heavily on primer binding sites for structure and function than
aptamers developed from longer library pools (Lozupone et al.,
2003). This is understandable, to be compatible with common PCR
polymerase, SELEX primers are designed generally with around 20 nt.
The disproportional structure displayed by pools with short random
regions certainly impose heavier impact on the SELEX procedure.
Therefore, libraries with random region of 30–50 nt are mostly
preferred (Cowperthwaite and Ellington, 2008).
The ultimate strategy to eradicate the effect of primer-binding site is
to simply delete it by using primer-free (or minimal-primer) libraries
(Fig. 3) (Pan and Clawson, 2009; Tsao et al., 2017). However, em-
ploying primer-free libraries do present additional complications.
Firstly, the additional costs and time by introducing restriction and li-
gation enzymes has to be considered. Secondly, as one of the most in-
efficient molecular biological reactions (generally 30-50%), the in-
troduction of a ligation step could result in a significant loss of potential
binders and compromise the advantage of implementing such strategy
(Kuo, 2011). Lastly, additional steps associated with purification and
separation surely introduce uncertainties and complexities to the al-
ready complex SELEX procedure. Consequently, in reality, this strategy
is hard to be advantageous over conventional methods and rarely em-
ployed in current SELEX practice.
In the case of genomic SELEX, however, primer-free library is
strongly recommended. As mentioned in Section 2.1, genomic SELEX
using genome encoded RNA or DNA as libraries focus on identifying
regulatory domains rather than developing target-binding aptamers.
Differing from normal SELEX in which the blockage of a certain amount
of random sequences generally does not affect the overall experiment,
annealing of primer binding sites with functional regions within
random fragments of a genomic library could lead to inappropriate
selection. Shtatland et al. conducted genomic SELEX using E. coli
genome fragments, and demonstrated that by interacting with random
regions, the fixed primer binding sites of the library resulted in a large
number of experimental artifacts, approximately 90% of the generated
sequences were represented by artifacts rather than sequences pre-
sented on the genome (Shtatland et al., 2000). In addition, it should be
noted that even when primer-free strategy is applied, as illustrated in
Fig. 3, PCR is unavoidable, which is enabled by ligating primer binding
sites to the ends of genomic sequence fragments after each round of
incubation and enrichment. As discussed previously, any sequences of
the random region displaying strong interaction with the constant
primer binding sites may detrimentally affect PCR amplification. If it
happens that the random sequences show strong interaction with the
ligated primer binding sites during PCR, it may influence the success of
SELEX. To resolve this problem, it is suggested to conduct parallel
primer binding site experiment (during ligation steps, introducing more
than one set of primer binding sites to the random region)
(Zimmermann et al., 2010). At the same time, via employing next
generation sequencing (NGS) technique to (1) minimize the SELEX
rounds and (2) compare information collected from different primer
binding site groups to identify potential sequences for functional study.
2.2.2. Constant regions rather than primer binding sites
Apart from the primer-binding site, other types of constant regions
can also be observed in published SELEX libraries. One example is the
partially randomized (doped) library or segmented library (Santosh and
Yadava, 2014). A feature of this type of library is not total randomi-
zation, but a limited variation of nucleotides within a known sequence.
This is because the purpose of this type of library is to determine and
improve the binding regions of existing aptamers or for functional
analysis of endogenous oligonucleotide by introducing carefully de-
signed constant regions (Santosh and Yadava, 2014). In another case,
libraries used in Capture SELEX (Istamboulie et al., 2017) provide an
excellent example in which a constant region is utilized for a purpose
rather than enhancing the binding capacity of libraries (Fig. 4). Ori-
ginally designed to develop aptamers against small molecules (e.g. ATP,
GTP, metal ions) that could not be immobilized, this type of SELEX
featured by immobilizing the library sequences to a solid phase via
docking the constant sequences (Fig. 4). When library sequences bind to
target molecules, the interaction between library sequence and the
target molecule can result in the 3-D formation change of the docking
structure of some library sequences and results in sequences dissocia-
tion. Since only sequences undergoing structural shift upon target
binding could be released from the solid phase, this method is suitable
to develop structure-switching aptamers ready for engineering analy-
tical sensors, such as fluorescent beacons for the detection of target
molecules.
Importantly, for both of these partially randomized library pools,
extra care should be given to primer- binding site design so that the
primer-binding site does not conflict with the folding or accessibility of
the known constant regions.
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2.3. Introduction of functional motifs for high quality libraries
The overall success rate of developing high affinity aptamers is
generally lower than their antibody counterparts (Mercier et al., 2017).
One reason lies in the nature of its structure. The binding sites of an
antibody are formed by six segments of variable structures composing
110-130 amino acids of 20 different species (Schroeder Jr. and
Cavacini, 2010). In contrast, a typical aptamer consists of 10 – 40 nu-
cleotides of 4 nucleotide species. The structure variations created by
aptamers are much less than antibodies. Also, unlike nucleotides, dif-
ferent amino acids in antibodies display a much greater variety of
physiochemical properties such as charge, solubility, and pKa, which
are all critical factors for target binding. In this section, we focus on
strategies made in recent years aiming at expanding functional motifs
and introducing protein-like properties to aptamers.
2.3.1. A simple way to increase the functional motif of initial libraries
Theoretically, during NA library synthesis, the maximal sequence
diversity can be achieved by equally inputting the four types of nu-
cleotides and thus increasing the probability of selecting high affinity
aptamers. However, it was found that diversity only may not be suffi-
cient to define a good library (Thiel et al., 2011). In three independent
Fig. 3. Illustration of typical methods for primer-free library and minimal primer library design. The design of both types of libraries takes risk of introducing extra
uncertainties during restriction enzyme digestion, ligation and PCR amplification.
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cases, smoothly-randomized initial libraries were used for aptamer
development, and it was found that the selection progress is accom-
panied by a steady decrease in the overall minimum free energy of the
libraries and an accumulation of pyrimidine-rich sequences (Thiel et al.,
2011; Takahashi et al., 2016). These findings suggest that a bias of the
GC region may create libraries with improved structural stability and
gain selective advantages during SELEX progress. This hypothesis was
supported by a computer-based analysis of the structure distribution of
the 40 nt random region of a library (Gevertz et al., 2005). As reported,
a slight shift to G and C (30% each) led to the predominant formation of
structures with more stems and more complex 3-D structures when
compared to an A and T shift. In fact, it has long been recorded in
genomic studies that genomic RNA sequences from archaea, bacterial to
eukaryote all display a GC enrichment pattern, implying the capacity of
this pattern to result in more complex structures for various biological
functions (Mann and Chen, 2010). As a result, instead of using
smoothly-randomized libraries, slight GC biased libraries with G: C: A:
T proportion of 3:3:2:2 was suggested (Vorobyeva et al., 2018). In an-
other case, when an RNA library was studied, Knight et al. proved a
combination of 25% U, 15% C, 20% A, and 40% G could maximize the
probability of identifying aptamers targeting targets to as high as 99%
even when the size of initial library was lowered to 6.23 × 109 species
(Knight et al., 2005), 10,000 times lower diversity than a standard
SELEX library.
2.3.2. Computer based library design
Inspired by the fact that library quality can be improved by simply
adjusting base composition, a series of computer-based library design
have been performed, aiming at providing initial libraries with opti-
mized structural patterns for enhanced binding potential (Chushak and
Stone, 2009; Kim et al., 2007; Luo et al., 2010). Indeed, as a type of
genetic entity, NA libraries display a combinatorial diversity and
complexity that pose many questions that are well suited to computa-
tional analysis, which is further powered by the rapidly developed NGS
technology and bioinformatics approaches for functional NA motif
identification.
2.3.2.1. Patterned SELEX libraries. Like proteins, aptamers require a
secondary structure to bind their targets. As reported, with 4n (equals to
the number of nucleobases) species of oligonucleotides, a typical NA
library contains up to 1015 sequences, this makes up an enormous,
highly diverse library for aptamer selection (Wu and Kwon, 2016). With
such a library, one would expect that aptamers can be developed for
any target imaginable. Unfortunately, the success rate of SELEX is
merely 30% (Famulok and Mayer, 2014; Zhuo et al., 2017), confounded
by many sequences in a library displaying simple structural motifs and
unstable structures, both of which would be unlikely to form high
quality aptamers. By introducing designed patterns favoring
information-rich structures into the random region of a library, the
occurrence of functional secondary structure could be considerably
increased, and therefore represents a practical way to design high
efficiency SELEX libraries. During the past decade, a couple of
computational approaches have been applied in this area. Moreover,
effective NA distribution patterns and general disciplines for new
library design have been suggested.
2.3.2.1.1. G-quadruplex. The first exploited pattern is the well-
described G-quadruplex structure, a kind of high-order structure
formed by G-rich sequences (Fig. 5) (Ishizuka et al., 2017). In a way
similar to antibodies, G-quadruplex structures couple a common
scaffold to varying loop motifs that act in target recognition (Edwards
et al., 2015). Besides, the four-stranded structures of G-quadruplex
allow enhanced hydrophobic binding to various types of targets such as
nucleolin, hemin, and light-up fluorogens (Trachman et al., 2017;
Warner et al., 2014). Unsurprisingly G-quadruplex motifs have been
observed in a significant proportion of published aptamers (Marusic
et al., 2013; McManus and Li, 2013; Varizhuk et al., 2016). Developing
libraries with a pre-designed G-quadruplex structure is likely to
increase the quality of initial libraries.
Interestingly, it was found that G-quadruplex structures in general
show correlation with certain biological functions (Varizhuk et al.,
2016). For example, by investigating the interaction of 12 in-
tramolecular G-quadruplex structures in different cancer cell lines,
Chang et al reported that the intramolecular parallel G-quadruplex
appears to be essential for cancer-selective anti-proliferative activity
(Chang et al., 2013). This observation is consistent with another study
in which the G-rich libraries with structural features of G-quadruplex
strongly inhibit cancer cell growth while sparing non-malignant cells
(Choi et al., 2010). This implies that the general G-quadruplex scaffolds
can be used to develop aptamers with particular biological functions.
In an early study, to obtain G-quadruplex enriched libraries, Zhu
et al. designed three 81 nt ssDNA libraries containing up to 45% gua-
nine bases within the 45 nt random region to evolve hemin-binding
DNA aptamers (Zhu et al., 2012). Recently, Simon et al. improved this
work by introducing a pre-designed G-quadruplex pattern in the
random regions (McManus and Li, 2013). In this latter study, a two-
layered G-quadruplex patterned library was generated by interspersing
different random-sequence domains for loop formation. Via Circular
dichroism analysis, the author confirmed that libraries with a minimum
of three and maximum five such interspersed sequence domains are
sufficient to form stable quadruplex structures featuring all three types
of known quadruplexes (parallel, antiparallel, or mixed-type hybrid) for
Fig. 4. Capture-SELEX provides an example to immobilizing SELEX library to
avoid non-specific binding. Capture-SELEX is featured by immobilizing the li-
brary sequences to solid phase via docking of the constant structure (step 1,2,3).
During target/library incubation (step 4), aptamer candidates displaying
structural change of the docking structure can be eluted (5) to incubation so-
lution.
T. Wang et al. Biotechnology Advances 37 (2019) 28–50
33
SELEX (Fig. 5). Surprisingly, being a semi-randomized library, in-
troducing pre-designed G-quadruplex pattern to the random region of
SELEX libraries seems not to compromise their sequence diversity. As
shown in the study conducted by Bugaut et al., small changes of the
loop length or sequence in loop regions of certain oligonucleotides
could result in dramatic changes from one stable quadruplex topology
to another (Fig. 5) (Bugaut and Balasubramanian, 2008; Miyoshi et al.,
2005). Theoretically, a total of 26 possible loop orientation topologies
could be formed by quadruplexes containing only three loops (Webba
da Silva, 2007). Consequently, the introduced G-quadruplex region
significantly increases the structural complexity and diversity, and
therefore potential functional motifs necessary for successful SELEX.
However, it should be noted that although G-quadruplex libraries
can increase the chance of obtaining aptamers, this type of library tends
to bind to a lot of targets, especially hydrophobic molecules, which
raises concerns of non-specific binding (Mcrae et al., 2017). Another
challenge for G-quadruplex library is the fact that these structures are
relatively hard to amplify by PCR enzymes, owing to the tendency of
polymerases to stall at G-tetrad sites (Ruggiero and Richter, 2018). As
reported, in the presence of K+, the melting temperature of a G-quad-
ruplex structure could be as high as 99 °C (Stevens et al., 2015), in-
accessible for currently available polymerases. Therefore, sequences
containing G-quadruplex structures may display amplification dis-
advantages during PCR reactions of the SELEX selection (Ruggiero and
Richter, 2018). Efforts have been made to solve this problem as re-
ported by Stevens and colleagues. Although Mg2+ favours G-quad-
ruplex conformation, the combination of K+ and Mg2+, as present in
PCR buffer, appears to have a more significant stabilising impact on G-
quadruplex structure (Stevens et al., 2015). As a result, excluding K+ in
the buffer but retaining Mg2+ required for the polymerase activity re-
presents a practical method to amplify G-quadruplex libraries. To fur-
ther minimise the detrimental effect of G-quadruplex on PCR reaction,
strategies such as employing strict selection conditions, high efficiency
DNA polymerases, and minimizing PCR rounds by new technologies
(i.e. high-resolution capillary electrophoresis) are also recommended.
2.3.2.1.2. Other types of patterned libraries for SELEX. Apart from G-
quadruplex, computational approaches were used to design other types
of patterned libraries including a DNA library with enriched stem-loop
structures by alternating purine and pyrimidine nucleotides (Ruff et al.,
2010). This study demonstrated a considerable enrichment of stem-loop
structures in the patterned library as compared to a random library via
the sequencing of library pools consecutively selected for 10 SELEX
rounds. Aptamers targeting streptavidin, immunoglobulin E (IgE), and
vascular endothelial growth factor (VEGF) were developed using this
library (Ruff et al., 2010). This alternating purine and pyrimidine
patterning method was further improved by Martin et al. by using
UNAFold software to increase the structural complexity of a DNA
library (Martin et al., 2015). First of all, a set of criteria were defined to
create libraries with maximized proportion of potential binders: (1) the
first nucleotide of each sequence must pair with the final nucleotide; (2)
the total number of unpaired bases must be between 10 and 30 for a 50
nt long sequence; (3) there must be at least two stretches of 4-unpaired
nucleotides. Then, random sequences were automatically input and
eventually 50000 sequences that fit all these criteria were selected. As a
result, with merely 50000 sequences incorporated onto a microarray
chip, effective aptamers were selected via a single round selection.
Although only thrombin was tested in this experiment, it highlights the
high value of applying a computational method for library design.
Importantly, although patterned pool appears to be one approach that
can be readily implemented in selections for rare/complex functions
(McManus and Li, 2013; Pobanz and Luptak, 2016; Ruff et al., 2010),
structure-promoting patterned library itself displays less sequence
diversity than ordinary libraries. It is important to conduct careful
investigations to design such libraries to avoid decreased diversity and
Fig. 5. Schematic representation of the formation and struc-
tural features of G-quadruplex. (A) G-quadruplexes are
formed by guanine tracts interspersed with three loops and
(B) stabilised through stacked, Hoogsteen base-paired, planar
G-tetrads. (C) The change of sequences in loop regions or
change of loop lengths could resulted in changes of G-quad-
ruplex topology among the three typical types.
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specificity. As demonstrated by Pobanz and colleagues (Pobanz and
Luptak, 2016), over-engineering the starting pools may be detrimental
to the success of selection.
2.3.2.2. Smart library and in silico SELEX - future aptamer
development. The incorporation of NGS and SELEX was firstly
practiced in Genome-SELEX to identify endogenous ligands from
genomic DNAs (Jolma et al., 2010; Roulet et al., 2002). Nowadays,
the NGS technique coupled with computational algorithms enables the
comprehensive identification of rare functional motifs in selected
aptamers and quantification of their abundance. Since such functional
motifs can be used as one descriptor for the target (Beier et al., 2014),
Beier and colleagues introduced a novel randomization strategy to
adjust the shape of the random region of a library to fit the structure of
a certain molecule or a class of molecule. However, the developed
target-specific NA library requires an extensive structural
characterization of not only targets but also SELEX libraries, and
therefore is too complicated to be generalized to various molecular
targets. Even so, the idea of identification of common motifs from
published aptamers and introducing such particular sequence or
structural elements to libraries have great potential in improving the
selection efficacy of libraries. Soon, the search of common motifs of
aptamers against particular targets or a group of targets was extended
to searching for common motifs present in aptamers targeting a vast
variety of targets (Hamada, 2018). Upon recognizing a five-way
junction structure as one of the most structured elements and
involves in a variety of different functional roles, Luo et al. developed
a computational method, named Random Filtering to generate starting
DNA libraries with increased structural diversity (Luo et al., 2010).
Firstly, by analyzing all of the secondary structures of a library, only
sequences containing higher complexity five-way junction structures
are isolated, and then, for each sequence, a set of mutant versions is
generated with all four possible nucleotides at all positions not involved
in base pairing. Random Filtering thus pre-enriches the starting library
with highly-structured five-way junction motifs. During subsequent
studies, it was found that this type of library provides complex spatial
structures favorable for the selection of aptamers against targets
difficult for aptamer identification with traditional NA libraries (Luo
et al., 2010). Instead of simply increasing the number of five-way
junctions in library pools, Genetic Filtering strategy was designed as an
improved edition of Random Filtering, allowing researchers to develop
library pools with desired junction structure distribution. For example,
to develop libraries with 20% 1-way (1J), 2-way (2J), 3-way (3J), 4-
way (4J), and 5-way (5J) junctions (Luo et al., 2010). Similar to the
Random Filtering method, Genetic Filtering strategy exhibits higher
structural complexity and can be used to increase the overall structural
diversity of initial pools.
The aptamer affinity maturation technique represents another pro-
mising computational method for aptamer development and affinity
enhancement. Evidently, although an aptamer identified by classical
SELEX may not always be the best aptamer with high affinity and
specificity, however, the best possible aptamer sequence can be iden-
tified from the selected aptamer family. Based on this hypothesis and
existing aptamer sequence information, Julian and colleagues designed
a novel library via Resample software. After a single round of micro-
array-based selection, the binding affinity of the aptamer pool was
improved by an order of magnitude (Kinghorn et al., 2016).
Recently, the effort aiming at developing optimised libraries has
resulted in the development of computer based in silico selection (Rabal
et al., 2016). Indeed, with the ever-growing aptamer database and ra-
pidly progressing 3D modeling of existing aptamers, together with
structural characterization of target molecules and sophisticated
docking programs such as RosettaDock, 3dRPC, FTDock, GRAMM and
PatchDock (Marze et al., 2018), it is possible to model and predict the
target-aptamer interaction without physically conducting SELEX.
However, three obstacles weigh heavily against the reliability of in silico
selection. Firstly, the ability to predict de novo target-aptamer interac-
tions relies strictly on well-characterized aptamers. This is not really
practical given the fact that current aptamer databases are still limited;
secondly, most of the suggested docking programs model protein–pro-
tein interactions (Ruff et al., 2010), their validation and accuracy in
predicting target-aptamer interaction is questionable. Lastly, the highly
specialized selection conditions such as metal ions, temperature, and
different bio-fluids make it difficult to mimic and therefore pose extra
challenges to the reliability of in silico selection. Even so, computer
based structural characterization and 2D structure clustering could
greatly expand our knowledge about aptamer-target interaction and
represent very promising strategies for future aptamer development.
2.3.3. Modified and synthetic genetic polymers expand the functional motif
of SELEX libraries
Although aptamers are a relatively new research field, applying
chemically modified genetic polymers (also known as xeno-nucleic
acids or chemically modified unnatural nucleotides) on antisense oli-
gonucleotides (AONs) for enhanced stability and minimized im-
munogenicity has been practiced for more than ten years before apta-
mers were introduced (Shen and Corey, 2018; Veedu and Wengel,
2009). Indeed, apart from desired physiochemical properties, chemi-
cally modified genetic polymers provide extra chemical spaces to ex-
pand the functional motif of SELEX libraries and therefore represent an
excellent platform for novel SELEX library design. As demonstrated by a
recent comparative study, chemically modified SELEX libraries, espe-
cially libraries containing hydrophobic characteristics, can generate
aptamers with an affinity of nM or even pM for proteins that had re-
peatedly failed using conventional DNA libraries (Rohloff et al., 2014).
Consequently, chemically modified libraries are currently being applied
in most of the aptamer clinical studies (Yoon and Rossi, 2017) and by
various leading groups such as Sullenger's group at Duke University (2′-
Fluoro, 2'-O-methyl and 2'-OH nucleosides) (Blind and Blank, 2015),
AM Biotech at UT Houston (Phosphorodithioate, 2'-O-methyl and X-
modified dU) (Lokesh et al., 2017) and Somalogics (SOMAmers mod-
ified nucleosides) (Rohloff et al., 2014).
2.3.3.1. Existing chemically modified genetic polymers for library
design. With a large bank of existing toolkits, chemical modifications
can be introduced into different parts of nucleic acids such as the base
(e.g. 5-methyluridine, pseudouridine, and dihydrouridine), sugar (e.g.
2′-O-methyl, 2′-Fluoro, 2′-FANA (2'-fluoroarabino nucleic acid) and
LNA (locked nucleic acid), or backbone (e.g., morpholino, peptide
nucleic acid, phosphorothioate and boranophosphate), though it is the
sugar, especially the 2′-OH position, that has been most extensively
exploited (Ni et al., 2017; Pinheiro et al., 2012; Veedu and Wengel,
2010). In fact, the only approved aptamer-based drug, Macugen, is
modified in this manner, by 2′-fluoro and 2'-O-methyl substitutions
(Wang et al., 2017a, 2017b). Another promising modification
candidates rising in recent years is the slow off-rate (e.g., low
dissociation rate constants) modified aptamers (SOMAmers) (Rohloff
et al., 2014). SOMAmers are DNA aptamers containing 2′-deoxyuridine
nucleotides that have modifications on the C5 position of the base. With
such a modification, the uracil could be added with a variety of residues
(e.g., benzyl, 2-napthyl or 3-indolyl-carboxamide) that mimic and even
exceed the structural diversity displayed by amino acids. Since its first
report in 2010 (Gold et al., 2010), SOMAmers targeting more than 3000
different human proteins ranging from growth factors, cytokines,
enzymes, hormones, and receptors have been developed (Eid et al.,
2015). Moreover, the SOMAscan™ proteomic assay based on
SOMAmers is now commercially available. Recently, the structural
study of SOMAmers and corresponding protein targets, once again,
confirmed that the introduction of hydrophobic moieties to libraries
contributes significantly to the interaction between aptamers and their
corresponding targets (Davies et al., 2012; Gelinas et al., 2014). Indeed,
the ability to incorporate hydrophobic moieties by chemical
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modifications solves a longstanding weakness of aptamer technology.
2.3.3.2. Synthetic genetic polymers – new tools for future aptamer
development. In the past decade, the arduous journey in search for
additional base pairs (Fig. 6) have greatly expanded the understanding
of biological evolution and shook our common belief of the origin of life
(Chaput et al., 2012; Herdewijn and Marliere, 2009). From the view
point of aptamer development, by introducing artificial base pairs apart
from A-T, C-G, together with existing chemical modifications, the
functional motifs of a library could be significantly expanded.
The idea of introducing an extra artificial base pair was firstly
practiced by Sefah et al. in their AEGIS-SELEX (artificially expanded
genetic information system - SELEX) (Sefah et al., 2014). In this study,
the starting library is composed of the four naturally occurring nu-
cleotides and two artificial nucleotides, 2-amino-8-(10-β-D-2-deoxyr-
ibofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one (P) and 6-amino-
5-nitro-3-(10-β-D-20-deoxyribofur-anosyl)-2(1H)-pyridone (Z). With
established strategies and enzymatic tools to manipulate such artificial
oligo nucleic acids for PCR amplification, cloning, and sequencing, new
horizons for developing aptamers with unprecedented properties was
realized (Sefah et al., 2014). Recently, Morales et al. developed 7-(2-
thienyl) imidazo [4, 5-β] pyridine (Ds) and 2-nitro-4- propynylpyrrole
(Px) base pairs (Kimoto et al., 2017). Differing from any previously
reported base pair, this base pair depends on shape complementarity
rather than hydrogen bonding (Fig. 6). This invention is biologically
significant as it proves that hydrogen bonding is not a definite
requirement for replication. Importantly, the strong hydrophobic
property of Ds makes it SELEX-friendly. Based on this technology, a new
type of SELEX library containing several artificial Ds-Px base pairs was
developed by Kimoto and colleagues (Kimoto et al., 2016). The selected
VEGF-165 and INF-c aptamers displayed 100-fold higher binding affi-
nity as compared to the non-modified analogs (Okamoto et al., 2016).
As a result, Ds-Px base pair was recently used by several leading ap-
tamer groups such as TagCyx Biotechnologies - Ichiro Hirao's group
(Hirao and Kimoto, 2012). Importantly, a couple of artificial base pairs
either employing hydrogen bonding or shape complementarity have
been reported during the past decade (Benner et al., 1989; Betz et al.,
2012; Ma et al., 2016; Negi et al., 2017; Sismour and Benner, 2005;
Switzer et al., 1993) (Fig. 6), they are expected to play important roles
in future aptamer development.
2.3.3.3. Spiegelmers – exploiting the bio-stable feature of mirror-image
oligonucleotides. Normal RNA or DNA aptamers consisting of native
nucleic acids are highly susceptible to the omnipresence of nuclease
enzymes in virtually all biological fluids. The serum half-life of which
could be as short as several seconds (Zhou and Rossi, 2016). To endow
better drug-like properties to aptamers, various techniques have been
introduced. As mentioned above, the serum stability of aptamers could
be significantly enhanced by employing chemically-modified SELEX
libraries. However, this method comes with a problem of
incompatibility in enzymatic enrichment of selected aptamers, and
increased selection cost (as well as other obstacles detailed in Section
Fig. 6. The artificial base-pairs. (A) Schematic fig. of two types of artificial base-pairs; (B) Examples of existing artificial base-pairs for future aptamer development.
(C) Molecular formula of artificial base-pairs.
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2.3.3.3). Post-SELEX modification via exchanging native nucleic acids
of an aptamer with chemically modified bases represents a more
popular method for enhanced aptamer physico-chemical properties
including high stability (Gao et al., 2016a). However, in many cases,
this stabilization process cannot be used to replace native bases to
chemically-modified bases which may change the conformation of
aptamers, necessary for target binding (Gao et al., 2016a). The
mirror-image aptamers, firstly introduced by Klussmann and
colleagues represent an alternative option in this respect (Klussmann
et al., 1996). Also known as spiegelmer, mirror-image aptamers are
built from non-natural L-nucleotides (mirror-image of natural D-RNA or
DNA) that is not recognized by the ubiquitous plasma nucleases
(Eulberg and Klussmann, 2003). Like any other enzyme in the human
body, the naturally occurring nucleases responsible for the degradation
of oligonucleotides consist of chiral building blocks (made of L-amino
acids). Their catalysing function is strictly stereo-dependent, only
native nucleic acids composed of D-nucleotides could be recognized
and processed (Eulberg and Klussmann, 2003). Therefore, unlike
normal aptamers, L-oligonucleotide made spiegelmers could escape
from nuclease recognition rendering high bio-stability. In an early
study, after a 60h incubation of an adenosine binding spiegelmer with
serum, no evidence of degradation was observed (Klussmann et al.,
1996). Having obvious stability advantages, various spiegelmers
against pharmacologically attractive targets were reported during the
past decades (Hoehlig et al., 2013; Kulkarni et al., 2007; Menne et al.,
2017), and three of them (emapticap pegol, olaptesed pegol, and
lexaptepid pegol) entered in clinical trials (Vater and Klussmann,
2015). Notably, all of them were tested for systematic administration
for cancer treatment, unlike other aptamer related clinical trials, which
are normally designed for local administration (such as Macugen).
Spiegelmer technique holds great potential in expanding the current
aptamer-based clinical applications.
However, being a type of aptamer made of non-natural nucleotides,
spiegelmers do have disadvantages. First, spiegelmers cannot be di-
rectly obtained by employing the ordinary SELEX process (Vater and
Klussmann, 2015). L-nucleotide cannot be recognized and processed by
native enzymes involved in SELEX such as PCR polymerase and tran-
scriptase/reverse transcriptase (Vater and Klussmann, 2015). As de-
monstrated in Fig. 7, the current spiegelmer identification relies on the
development of conventional, D-config.d aptamers against a synthetic
non-natural L- config.d target that is the mirror-image of the biological
target of interest. Then, by synthesizing the identified aptamers with
non-natural L-nucleotides, spiegelmers against the target of interests
could be developed. According to the rules of symmetry, the developed
L-config.d spiegelmers should be able to bind to the natural target with
identical binding properties as the conventional D-aptamers bind to the
mirror-image target used for SELEX (Klussmann et al., 1996). Secondly,
unlike conventional aptamers which can be developed theoretically to
any targets, spiegelmers can only be developed for targets with chiral
properties such as protein and peptides. Thirdly, an inherent compli-
cation of developing mirror-image spiegelmers is the requirement of
synthesizing the non-naturally L- config.d form of the target of interest.
If the SELEX as shown in Fig. 7 was carried out against a natural target,
the developed spiegelmers would only recognize an unnatural L-con-
figurated target. Spiegelmers are normally developed by targeting low
molecular weight peptides such as epitopes or domains of the whole
proteins (Kulkarni et al., 2007). In this case, to make sure that the
developed spiegelmers can recognize the peptide segment in the context
of the whole protein, the targeted epitopes or domains are required to
be (1) physically stable; (2) located on the surface of the protein; (3)
functional, or at least close to a functional site (when biologically
functional spiegelmers are required) (Vater and Klussmann, 2015).
Lastly, although displaying extraordinary stability, spiegelmers show an
identical binding property with their D-config.d aptamers counterparts,
additional efforts may be required to improve its chemical space for
enhanced binding properties.
2.3.3.4. Challenges and solutions for the application of modified and
synthetic genetic polymers. The expansion of the genetic code does
bring along limitations. For example, for the Ds-Px base pair-based
platform, the locations of the Ds nucleotides must be fixed, and a
tagging system is required to keep track of their location and number in
a sequence (Wang et al., 2017a). This means that the sequence is not
fully randomized, thus limiting the diversity of the starting libraries.
Yet the biggest challenge comes from the compatibility of existing
enzymes to unnatural nucleotides (Lapa et al., 2016). Of note, many of
the currently applied chemical modifications are based on strategies
developed for in vivo application of AONs. Different from the
application of AON, which does not rely on auxiliary enzymes, the
incorporation of modified nucleotides especially non-hydrogen bonding
base pairs into SELEX library comes at the cost of enzyme fidelity and
processivity, making critical steps of SELEX such as RNA transcription,
PCR amplification, and sequencing difficult (Lipi et al., 2016; Sefah
et al., 2014). This is one of the reasons why such a promising strategy
has not yet become routine in ordinary laboratories. To increase the
compatibility of enzymes to different types of chemical modifications,
various mutant versions of enzymes have been developed. By a method
similar to SELEX, Pinheiro and colleagues developed a system termed
self-tagging strategy to develop DNA polymerases compatible with
certain chemical modifications (Pinheiro et al., 2014). Firstly, a library
of mutated polymerases was constructed and then by reacting with
chemically modified nucleotides, the best polymerase for a particular
Fig. 7. An illustration of in vitro Spiegelmer selec-
tion. The mirror-image of the natural L-configuration
target was synthesised using unnatural D-configura-
tion materials. The SELEX is then carried out using
natural enzymes and D-configuration natural nucleic
acid libraries against the D-target. After several
rounds of SELEX, an aptamer displaying binding to
the D-target was identified. To produce an aptamer
being able to bind the natural L-configuration target,
the mirror-image of the identified D-aptamer was
synthesised using unnatural L-nucleic acid, which
displaying resistance to nuclease attack.
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type of modification was selected. Subsequently, this method was used
to develop polymerases compatible with various modifications such as
cyclohexenyl nucleic acid, LNA, altritol nucleic acid, arabinose nucleic
acid, and 2'-Fluoro arabinose nucleic acid (Pinheiro et al., 2012). In a
recent study, via fine-tuning the modified bases and mutated DNA
polymerase, even Ds–Px pair, the non-hydrogen base pair can undergo a
hundred cycles of PCR with 97% fidelity (Yamashige et al., 2012). With
all these efforts, nowadays, a number of mutant polymerase variants,
such as Phusion, KOD XL, and Deep Vent DNA polymerase have become
commercially available (Lapa et al., 2016). To be sure, with the
development of more and more novel enzymes, the problem of
enzymatic compatibility of synthetic nucleotide polymers will be
solved soon.
Minimizing the rounds required for SELEX presents obvious ad-
vantages to address the problem of enzymatic compatibility. As dis-
cussed previously, the rapid progress in techniques such as Capillary
electrophoresis, Micro-assay system, and NGS platform has enabled the
development of a low round or even single round SELEX (Non-SELEX)
protocols (Hirose et al., 2017). However, the limiting factor for single-
round SELEX (or SELEX with minimal rounds) is that it typically re-
quires sophisticated equipment not commonly available for regular
laboratories.
A new type of SELEX procedure termed Click-SELEX provides a very
creative solution to bypass the necessity of employing enzyme mutants
for SELEX involving the application of chemically modified/ synthetic
libraries (Pfeiffer et al., 2018; Tolle et al., 2016) (Fig. 8). As illustrated
in Fig. 8, by using a 5-modified, commercially available pyrimidine
nucleoside-triphosphate (e.g. by replacing the canonical thymidine
building block with C5-ethynyl-2'-deoxyuridine, EdU) which can be
further derivatized with bio-orthogonal chemistry, Mayer G. et al. de-
signed a versatile platform allowing the introduction of additional
chemical entities to DNA libraries (Tolle et al., 2016). Importantly,
because the modification is only transiently present during the selection
cycle, this method enables a high degree of compatibility with the en-
zymatic step of the selection processes. What’s more, with a broad ac-
ceptance of diverse substrates, this method can be used to introduce
large chemical entities into libraries that cannot be achieved by current
techniques, thus endowing aptamers with more antibody-like proper-
ties.
To summarize this section, incorporating modified nucleotides into
SELEX libraries definitely brings along substantial benefits. It helps to
expand the diversity of the NA libraries for more versatility in binding
with different target molecules with nM or even pM affinity.
Meanwhile, the modified nucleotides also enabled improved bioavail-
ability and safety profile, making the developed aptamers ready for
various therapeutic and diagnostic applications.
3. Target preparation and its importance for bound/unbound
sequence separation
3.1. Immobilization of target molecules is predominant for target
preparation
A successful SELEX heavily relies on the efficient separation of li-
brary sequences bound and unbound to targets, to allow the evolution
of the best fitted sequences with the progress of SELEX (Spill et al.,
2016). In the first SELEX report, the separation of free sequences and
target-bound sequences was conducted by specific immobilization of
protein molecules via a nitrocellulose membrane (Tuerk and Gold,
1990). Firstly, the protein target and library were incubated in solution
and then the mixture underwent a nitrocellulose filtration, during
which proteins and sequences binding to proteins were immobilized on
Fig. 8. Click-SELEX allows amplification of chemi-
cally modified SELEX libraries using normal PCR
polymerase. The initial library is designed with 5’-
modified nucleoside-triphosphate, which can be
further functionalized with an azide-bearing mole-
cule via Click chemistry (CuAAC) (A & B1,2); After
incubation with the target molecule, the bound se-
quences are purified (B3,4) and amplified by normal
PCR enzyme using the alkyne-modified triphosphate
instead of thymidine (B5). Following PCR, the in-
troduced chemical modification will be removed and
the nucleoside-triphosphate moiety will be re-
introduced. Then, the single stranded DNA is pre-
pared by exonuclease digestion of the 5’phosphory-
lated antisense strand (B6). The chemical
modification of interest can be reintroduced by
CuAAC and forward to the next round of selection.
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the nitrocellulose membrane and free sequences simply pass through
the membrane. Because the targets were primarily proteins in the early
stage of SELEX, this nitrocellulose membrane based bound/unbound
sequence separation was used in several of the subsequent works.
However, this method has some limitations. It only works with proteins
(the non-specific affinity of nitrocellulose to amino acids is central to
this technique) and is incapable of binding small peptides. In addition,
because of the significant non-specific binding of free nucleic acids to
the large surface area of the nitrocellulose membrane, the enrichment
of target-binding aptamers could be significantly hindered, typically up
to 20 selection rounds are required (Szeto and Craighead, 2014).
To facilitate easy handling and stringent washing conditions for
effective bound/unbound sequence separation, prior to target/library
incubation, current SELEX protocols commonly immobilize targets
through solid substrates including magnetic particles (Bruno, 1997),
sepharose (Soldevilla et al., 2017), agarose-based resin (Kowalska et al.,
2014), microfluidic chips (Olsen et al., 2017) or glass coverslips
(Lauridsen et al., 2012). Among these solid phases, the magnetic beads
are perhaps the most employed. First introduced in 1997, by im-
mobilizing targets onto magnetic beads, the separation of target-ap-
tamer complex and unbound sequences could be achieved by a mag-
netic separator (Bruno, 1997). Importantly, by employing this bead
based method, the selection process could be monitored by not only
fluorescence based method (by introducing fluorescent tags such as
FITC at 5'-end of the forward primer, to create sub-libraries with
fluorescent label or introducing other molecules such as biotin to the 5'-
end of forward primer and detect these molecules by fluorescent la-
belled antibodies), but also the more accurate calibration plot (FluMag-
SELEX) (Lauridsen et al., 2012), flow cytometry (Wang et al., 2009) or
ELISA (Wang et al., 2015) based strategies. In fact, research of magnetic
utilization in SELEX has led to the development of various SELEX
strategies including the Magnetic-Assisted Rapid Aptamer Selection
(MARAS) and a couple of automatic SELEX platforms such as the mi-
crofluidic-based SELEX platform M-SELEX (Lou et al., 2009) and con-
tinuous-flow magnetic activated chip-based SELEX (CMACS-SELEX)
(Blind and Blank, 2015).
The efficiency of this solid phase immobilization method could be
affected significantly by two issues. Firstly, during incubation, some of
the library sequences might unwantedly bind to the immobilized ma-
trices (Darmostuk et al., 2015). To solve this problem, negative SELEX
or counter-SELEX are commonly conducted by incubating libraries with
matrices itself or matrices conjugated with a negative control target
before incubating libraries with matrices coupled targets (Mercier et al.,
2017). However, although rarely discussed, relying on negative or
counter SELEX to preclude unwanted aptamers is rarely as effective as
expected. As illustrated by Fig. 9, in the case of matrices/library
binding via a structure-dependent mode, negative or counter SELEX do
effectively eliminate non-specific binding. However, apart from struc-
ture-dependent mode, library sequences bind to matrices also follow a
structure-independent mode, for example, sequences could be non-
specifically captured by matrices surface or nonspecific electrostatic
absorption (Szeto and Craighead, 2014). In these circumstances, ne-
gative or counter selection will be ineffective since all sequences in a
library could bind to matrices with equal opportunity. Another problem
of solid phase immobilization lies in the chemical reactions required to
anchor the targets onto the matrices. In many cases, the immobilized
target could show a structure very different from its native state (Chen
et al., 2017). As a result, the binding affinity of the resulting aptamers
to the native state of the target may be compromised.
3.2. Electrophoresis allows target/library incubation in a matrices-free
condition
The first problem of the target immobilization method, i.e., non-
specific binding introduced by matrices is a critical problem for suc-
cessful SELEX. Being a classical method for protein- bound and
-unbound oligonucleotides separation, electrophoretic mobility shift
assay (EMSA) presents a separation strategy with minimized non-spe-
cific oligonucleotide binding (Wang and Reed, 2012). This method
starts by incubating protein targets with libraries in solution. Then the
mixture is added to native PAGE or Agarose gel for electrophoresis
separation. The principle of this strategy is that the mobility of oligo-
nucleotide–target complexes and unbound free oligonucleotides are
affected by their molecular weight. The oligonucleotides bound to the
target have a bigger overall molecular weight than free oligonucleo-
tides and show a slower movement. The gel blocks containing oligo-
nucleotide/protein complexes are then collected and the aptamer se-
quences could be eluted by various reported methods. In line with our
experience, the non-specific capture of library sequences by the gel
under the electrophoresis condition is very unlikely (data not shown),
which makes it both simple and promising. However, this method faces
a couple of challenges. Firstly, this method is only suitable for protein
targets; and secondly, very different with what happens in a denature
gel, the mobility of protein, protein-aptamer complex and free library
sequences are decided by not only the molecular weight, but also by the
electronic charge and shape of individual molecules. It should be no-
ticed that protein targets will surely undergo different conformational
change after binding to different oligonucleotide sequences and results
in a low gel resolution (Zhang et al., 2017). In addition, during gel
electrophoresis, it is difficult to control some of the crucial selection
conditions such as temperature, salt concentration, etc. (McKeague,
2017). Consequently, this method is not commonly used.
Powered by UV-LEDIF detection and high-resolution separation
techniques, Capillary Electrophoresis-SELEX (CE-SELEX) is able to
eliminate many of the disadvantages displayed by EMSA-SELEX via a
gel free electrophoresis strategy (Yang and Bowser, 2013). Similar to
the gel mobility method, in a CE-SELEX procedure, the targets and in-
itial libraries are incubated in solution. After the incubation, rather
than employing any solid-phase, the bound/unbound sequence se-
paration is conducted continuously in solution under strictly controlled
conditions. By performing the whole selection in solution, this method
increases the number and types of viable targets (including targets
smaller than the aptamer itself) for aptamer development (Yang and
Bowser, 2013). Apart from great separation resolution, CE-SELEX offers
flexibility to manipulate the selection stringency by varying target
concentrations, separation parameters, and collection window timing
(Riley et al., 2015). By employing such a strategy, one can not only
effectively separate bound/unbound sequences, but also, with proper
modification, separate bound sequences with different properties.
Consequently, various smart aptamers with predefined Kd, koff, kon
have been developed by novel CE-SELEX strategies such as ECEEM-
SELEX (Drabovich et al., 2005) and Sweep-CE-SELEX (Okhonin et al.,
2004). This not only extends the knowledge of aptamer–target complex
interactions, but also is extremely useful for the development of smart
drugs for therapy and diagnostics. As a result, even though the rela-
tively limited library input allowed for a typical CE-SELEX (1012 for CE-
SELEX versus 1016 for common SELEX), the high-resolution separation
of CE-SELEX greatly reduces the selection rounds required for aptamer
development (Yang and Bowser, 2013). In fact, CE-SELEX based single-
round selection has been reported by various groups in recent years
(Eaton et al., 2015; Yang and Bowser, 2013). Importantly, as a pro-
mising single/limited-round SELEX platform, the requirement for non-
natural nucleic acid compatible enzymatic reactions in CE-SELEX could
be considerably reduced, making it very suitable for chemically mod-
ified/synthetic non-natural nucleic acid-based libraries.
3.3. Immobilizing library sequences offers minimal non-specific binding
Although solid matrices mediated target immobilization tend to
incur non-specific binding of library sequences, it could be a completely
different story when the library sequences rather than target molecules
were attached to solid matrices. The previously discussed Capture
T. Wang et al. Biotechnology Advances 37 (2019) 28–50
39
SELEX (Fig. 4) is an example in this aspect (Istamboulie et al., 2017). As
discussed previously, Capture SELEX is characterized by immobilizing
the library sequences to a solid phase. Since only sequences interact
with targets and undergo structural changes could be eluted from the
solid matrices, this method offers a great idea to eliminate the non-
specific binding during the SELEX process. Nano-selection introduced
by Martin and colleagues is another creative idea to minimize non-
specific binding of library sequences to targets (Peng et al., 2007).
Simply put, a library of small beads is created with each of the bead
conjugating oligonucleotide with a single sequence. Then the library of
beads is flowed over the immobilized target molecules on a glass cover
slip. After washing, beads containing target-specific aptamers are
identified via an atomic force microscope (AFM)/fluorescence micro-
scope, and extracted from the cover slip via an AFM tip in a contact
mode. Conjugating a single sequence on each bead is the key advantage
of this type of SELEX. Firstly, differing from free oligonucleotides, the
chance of non-specific binding of beads (plus attached oligonucleotide
sequences) to target matrices is very low; besides, the conjugating li-
brary sequences on big-sized beads allows an accurate identification
and extraction of the sequence of interest from the matrices and ensures
a single round-SELEX. However, in this method, only one copy of an
oligonucleotide sequence is conjugated to each bead, which poses a
challenge for PCR amplification and subsequent sequencing. A loss of
sequence information is almost unavoidable. In addition, the equipment
used in this method makes it difficult to be generalized.
Recently, this protocol was significantly improved by the in-
troduction of Non-SELEX Bead-Based Selection (Lam et al., 2015;
Lokesh et al., 2017), one of the successful aptamer development plat-
forms in the market. In this method, multiple copies of the same se-
quence are conjugated to individual beads to create a library of 109
sequence species in total. By immobilizing targets on magnetic beads
rather than cover slip, the selection is simplified. Importantly, fa-
cilitated by chemically modified libraries with an improved formula,
this method allows researchers to develop aptamers targeting small
molecules or proteins with high binding affinities. And different from
the Nano-selection where only one sequence is conjugated to each bead,
with up to 105 identical sequences in the same bead, it is unlikely to
lose the sequence information during PCR amplification and sequencing
(Table 1).
3.4. Washing buffer can be modified to develop aptamers with predesigned
properties
For protein targeted aptamer selection, washing solution has been
explored for effective separation of not only bound/unbound se-
quences, but also the separation of sequences with preferred binding
properties. In 2013, the Giangrande group reported a method to elute
aptamers binding to cell surface membrane via a 0.5 M NaCl solution
(Hernandez et al., 2013). The principle of this method is based on the
ability of NaCl to break electrostatic interaction, which is believed to be
the main interaction between aptamer and protein targets (Hernandez
et al., 2013). Following this idea, in the same year, Arnold et al. de-
veloped a simplified one-round SELEX to generate aptamers against
Kalikreine-related peptidase 6 (KLK6) with predesigned binding affinity
(Arnold et al., 2012). Firstly, proteins were immobilized on a 96-well
plate and incubated with library sequences. Afterwards, unbound and
non-specifically bound aptamers were washed off by NaCl solutions
(gradient from 0.1M to 1M). According to this study, the most tightly
bound aptamers were eluted by the highest salt concentration, thus
allowing selection of aptamers with different binding properties. This is
a very straightforward and inexpensive approach. However, the success
of this method relies entirely on the prerequisite that the strongest
binder has the most stable structure. To the best of our knowledge, this
is not recorded by previous references. Surprisingly, strong denaturing
detergents such as Urea and even DNase І have also been employed as
elution buffer to remove non-specific or loose binding sequences after
target/library incubation (Liu et al., 2012). Although effective aptamers
have been developed via such methods, further studies are needed to
assess if stronger binders necessarily better resist urea mediated dena-
turing or DNase digestion. If it is confirmed to be true, such methods
would be of great value for the simple yet powerful concept it ad-
vocates.
Fig. 9. Negative selection is effective only when library sequences bind matrices in a structural dependent manner. (A) When library sequences bind matrices in a
structural independent manner, the conducted negative selection only minimized the library size and dose not decrease non-specific binding; in contrast, (B) when
library sequences bind matrices in a structural dependent manner, negative selection can effectively remove non-specific binding of library sequences to matrices.
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3.5. Whole cell as protein target carrier – a method to provide native state
proteins for SELEX
Different to all previously described SELEX methods, which are
based on the knowledge of the target for aptamer selection, in Cell-
SELEX, the whole cells, either eukaryotic or prokaryotic cells, are used
as targets (Civit et al., 2018). By employing proper negative controls,
Cell-SELEX allows researchers to generate aptamers not only to re-
cognize a particular type of cell, but also distinguish cells in different
states (e.g., healthy cells and cells under diseases). Consequently, in
recent years, Cell-SELEX has emerged as a promising strategy to iden-
tify novel biomarkers or unknown proteins of cells under study (Chen
et al., 2016) (Fig. 10). Recently, a couple of aptamers developed via
Cell-SELEX were used successfully in various applications such as dis-
ease diagnosis in clinical settings and microbe detection in food sci-
ences (Song et al., 2017). Importantly, with proper modification, we
believe this method can also be manipulated to develop aptamers
against subcellular organelles such as exosomes and microvesicles to
tackle various challenges present in current biological fields.
Apart from recognizing whole cells, Cell-SELEX can also be em-
ployed to develop aptamers targeting specifically to proteins in their
native states. As reported, protein targeted aptamers represent the
majority of the currently available aptamer sequences and have been
used to develop devices or drug delivery systems for various theranostic
applications (Liu et al., 2011). Unfortunately, it has long been observed
that aptamers selected from pure protein molecules may not be able to
bind to the same proteins in their endogenous state (e.g. in cells)
(Mallikaratchy, 2017). By using cells as the supplier of protein targets,
this problem can be solved. In 2001, Hicke et al. introduced a hybrid
SELEX that combines the advantage of Cell-SELEX and purified protein-
based SELEX (Hicke et al., 2001). Firstly, tenascin-C-bearing cells were
used as targets to select aptamers against tenascin-C in its native con-
dition. After several rounds, the selection was performed using purified
tenascin-C protein to improve the specificity of selected aptamers.
Later, this protocol was improved by Ohuchi and colleagues by in-
troducing cells displaying recombinant proteins as SELEX targets
Table 1
Current strategies for bound/unbound sequences separation.
Methods Advantages Disadvantages
Incubation of target & library in matrices-free condition
Nitrocellulose membrane filtration •Easy handling (Szeto and Craighead, 2014) •Only for protein (depending to
membrane size is incapable of
binding small peptides (Tuerk and Gold, 1990)
•low efficiency due to non-specific
binding of nucleic acids to membrane (Szeto and
Craighead, 2014)
Electrophoretic mobility shift assay (EMSA) •Easy handling
•Accessible to regular laboratory
•Enable real-time monitoring selection process (Wu and Kwon,
2016)
•Minimized non-specific binding (Wang and Reed, 2012)
•Only suitable for protein targets (Zhang et al., 2017)
•Low resolution resulted from
employment of native gel
electrophoresis (Zhang et al., 2017)
•Difficult to maintain stable selection
conditions such as temperature, salt
concentration (Wu and Kwon, 2016)
Capillary Electrophoresis •High-separation resolution enabling single-round selection (Yang
and Bowser, 2013)
• Suitable for a broad range of targets,
especially small molecules (Yang and Bowser, 2013)
•Developing smart aptamers with predefined properties (Kd, koff,
kon) by manipulating separation parameters (Riley et al., 2015)
•Minimized non-specific binding (Eaton et al., 2015)
•Need sophisticated apparatus
•Relatively limited library input (Ruff et al., 2012)
•Difficult to optimize separation conditions for some
proteins (Riley et al., 2015).
Immobilizing targets on solid phase & application of well-designed wash buffer
Beads, plates or cover slips •Easy handling (Bruno, 1997)
•Suitable for a broad range of targets (Paul et al., 2009)
•Accessible to regular laboratory
•Enable real-time monitoring selection process (Lauridsen et al.,
2012)
•Enabling high-throughput selection (Lou et al., 2009)
•Non-specific binding to the immobilized matrix
(Darmostuk et al., 2015)
•Method employed for target immobilization could affect
the native structure of targets (Chen et al., 2017).
Elute sequences with preferred properties
using salt, DNase, etc.
•Simple and inexpensive (Hernandez et al., 2013)
•Developing aptamers with preferred binding properties (Arnold
et al., 2012)
•The reliability needs to be further
investigated
Immobilizing library sequences on solid phase
Capture SELEX •Suitable to develop aptamers against small molecules that could
not be immobilized (Istamboulie et al., 2017)
•Minimized non-specific binding and selection rounds (Istamboulie
et al., 2017)
•Select aptamers undergoing structural-switching (Spiga et al.,
2015).
•Only aptamers undergo structural-
switching could be developed (Lauridsen et al., 2018)
•Introducing extra variations by docking sequences
(Istamboulie et al., 2017).
Nanoselection •Minimized non-specific binding
•Single round aptamer selection (Peng et al., 2007)
•Aptamer candidates can be physically identified and collected via
an atomic force microscope (AFM) and AFM tips (Peng et al., 2007).
•Immobilizing target molecules on
glass cover slips affect the native
structure of targets (Lauridsen et al., 2012)
•With only one copy of oligonucleotide
sequence is conjugated to each bead,
loss of sequence information by PCR
bias is unavoidable
•Need sophisticated apparatus (Peng et al., 2007)
Non-SELEX Bead-Based Selection •Minimized non-specific binding (Lam et al., 2015)
•Single round aptamer selection (Lam et al., 2015)
• Minimized the loss of sequence information by attaching multiple
copies of same sequence on each bead (Lam et al., 2015)
•Immobilizing target molecules on
beads may affect the native structure
of targets (Lauridsen et al., 2012)
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(TECS-SELEX) and the un-transfected wild type cells as negative se-
lection controls (Ohuchi et al., 2006). Since the protein targets are
prepared in living cells, this method enables the selected aptamer to be
used directly for diagnostic and therapeutic applications. Technically,
using cells as protein carriers has extra benefits since the negatively
charged cell surface membrane could effectively minimize the non-
specific binding of DNA libraries to cells by electrostatics and ensuring
higher success rate. In recent years, various Cell-SELEX derivatives such
as fluorescence-activated cell sorter (FACS)-SELEX (Mayer et al., 2010),
3D Cell-SELEX (Souza et al., 2016) and Cell-internalization SELEX
(Thiel et al., 2015) have been developed to select aptamers for different
purposes and possess numerous merits.
One of the concerns for TECS-SELEX lies in the observation that
regulating any particular gene in a cell could simultaneously affect on
average the expression of 20 genes (Coate et al., 2014). However,
considering the high efficiency of transient expression mediated by
plasmids, the overexpression of the expected gene would be much
higher than any other affected genes and therefore ensuring the
transfected cells remain valid as a positive protein carrier for SELEX.
Compared with the potential co-expression of irrelevant genes in TECS-
SELEX, the presence of dead cells is a major pitfall for all types of Cell-
SELEX (Sefah et al., 2010). This is because dead cells are likely to lead
to nonspecific uptake of library sequences and cause SELEX failure.
Although counter SELEX has been commonly used in Cell-SELEX to
minimize the effect of non-specific binding (Sefah et al., 2010), as in
any other type of SELEX, it can do nothing to sequence-independent
nonspecific binding (Fig. 9) caused by dead cells. To solve this problem,
microbeads have been used to remove dead cells prior to cell-library
incubation. However, a much easier and efficient method is to directly
use attached cells rather than cell suspension (used in many of the re-
ported protocols) to conduct Cell-SELEX. By using attached cells, dead
or weak cells cannot resist stringent washing and could be removed
during the SELEX procedure. And importantly, using attached cells is
beneficial as it can not only avoid cell damage during cell suspension
preparation, but also minimize the non-specific binding of library se-
quences to incubation containers, especially plastic containers, which is
apt to mediate sequence-independent nonspecific binding (Hong and
Sooter, 2015).
Last but not the least, considering the predominant use of proteins
as SELEX targets, we would like to address the importance of the origin
of protein for aptamer selection. As recorded, due to the different
process of post-translational modifications, aptamers obtained against
proteins expressed in prokaryotic systems tend to fail to bind to the
same target expressed in eukaryotic cells (Mercier et al., 2017). So,
when preparing proper protein targets for SELEX, care should be taken
when choosing expression cell systems. For example, to develop protein
targeted aptamers for human disease diagnosis or treatment, E. coli cells
are not suitable.
4. PCR reaction and PCR bias
4.1. Emulsion PCR is a potent method to address the problem of PCR bias
The law of “survival of the fittest” is reflected in SELEX by enriching
and amplifying only the library sequences displaying strong binding to
a target of interest via PCR. Ideally, to effectively select the best binder
from an initial library, after PCR amplification, the proportion of dif-
ferent sequence species in PCR amplicons should faithfully reflect the
component constitute of the original template. However, it has long
been observed that unlike amplifying homogeneous templates, PCR
amplification of complex oligonucleotide libraries with high variety is
very complicated (Polz and Cavanaugh, 1998). As each of the sequences
in the initial library has different structural properties such as GC
content, secondary structures, and melting temperature, their adaption
to DNA polymerase, primer, and other PCR conditions could be very
different. As a result, apart from the formation of the well-known PCR
by-products (PCR parasites) (Fig. 11B) (Tolle et al., 2014), the PCR
product tend to be biased toward shorter sequences or sequences adapt
better to the applied PCR polymerases (Head et al., 2014; Witt et al.,
2017), causing significant loss of sequence information during SELEX
process. As demonstrated by a recent study, with a single PCR reaction,
the diversity in a library could decrease by up to 50% (Levay et al.,
2015). Therefore, without proper control, the SELEX process is very
likely to fall into selecting sequences to fit best not to the target of
interest but the PCR system. The phenomenon of PCR bias is not ob-
served only in SELEX, it is also a significant challenge for any bio-
chemical reaction involving PCR amplification of heterogeneous tem-
plates such as NGS (Head et al., 2014). Unfortunately, although the
formation of by-products has been repeatedly reported in previous
SELEX work, apart from the commonly performed preparative PCR (or
analytical PCR) to determine optimum PCR cycles (Fig. 11A, will be
discussed in Section 4.3), this problem is rarely addressed. Recently, a
method termed RNA Aptamer Isolation via Dual-cycles SELEX (RAPID-
SELEX) was introduced to minimize PCR bias by systematically elim-
inating unnecessary amplification steps and performing amplifications
only when higher numbers of specific sequences or higher pool con-
centrations are required (Szeto et al., 2013). Obviously, it is not likely
to completely control the effects of PCR bias by simply omitting
Fig. 10. Major steps involved in Cell-SELEX. (A) Cell-SELEX allows to recognize particular cells; (B) Cell-SELEX allows to recognize bio-markers of cells.
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particular steps of SELEX. In the past years, the rapid development of
NGS technology lead to the invention of a novel PCR variation termed
Emulsion PCR (ePCR) (Kanagal-Shamanna, 2016), by encapsulating
each oligonucleotide sequence into an individual PCR droplet sur-
rounded by a hydrophobic organic phase, ePCR is able to significantly
reduce the PCR bias and the formation of by-products to a non-de-
tectable level. Nowadays, the ePCR has already emerged as a standard
method for sample preparation of NGS, and the related kits are com-
mercially available (Witt et al., 2017). This method may benefit future
SELEX in a significant way.
4.2. Concerns with PCR polymerases
PCR reaction does more than just enriching the survived sequences;
it has also been used to favor another important prerequisite of aptamer
evolution – sequence diversity. For this purpose, both error prone PCR
(introducing point mutations to parental sequences) (Pressman et al.,
2017) and a more effective non-homologous random recombination
(NRR technique enables DNA fragments to randomly recombine to in-
troduce additional diversity) have been developed (Bittker et al., 2002).
However, such strategies are hardly used in current SELEX practice. In
contrast, high fidelity PCR polymerases have been preferentially ap-
plied by the majority of the SELEX research groups. This is mainly
because the mutations and complicated procedures introduced during
error-prone and NRR PCR amplification inevitably add extra un-
certainties and complications to the “black box” SELEX procedure and
subsequent data analysis (Blank, 2016). And the up to 1015 sequences
present in a normal SELEX library, along with current chemical mod-
ifications, are generally believed to be sufficient to provide adequate
sequence diversity for a successful SELEX. However, it has been noted
that error prone PCR and NRR techniques seem promising for identi-
fication of functional motifs and improving the binding properties of
existing aptamer sequences, by creating a series of structural deriva-
tives of an exist aptamer sequence (Davis et al., 2017).
4.3. What makes an optimum PCR cycle?
The PCR procedure for SELEX commonly includes two steps, i.e.,
analytical (or preparative) PCR and subsequent amplification PCR
(Haghighi et al., 2018). The purpose of analytical PCR is to determine
the optimal number of cycles for amplification PCR by conducting PCR
with a series of cycle numbers. The optimal number is typically defined
as the cycle number displaying the highest yield of PCR product in the
expected position without a PCR by-product (one of the main obstacles
for SELEX failure (Tolle et al., 2014)) being detected (Shigdar et al.,
2013a, b) (Fig. 11A). Originally being estimated as a kind of primer-
primer hybridization (Musheev and Krylov, 2006), PCR by-product is a
unique product associated with amplifying high diverse templates.
Recently, the nature of PCR by-products was studied by Günter Mayer
and colleagues (Tolle et al., 2014). According to their results, PCR by-
products are initiated by partial binding of primer to complementary
bases appear on random regions of library sequences. The partial
binding structure is then extended by the polymerase to yield longer
DNA products with higher molecular weights than parental library se-
quences. Because long stretches of such by-products allow for more
efficient annealing during PCR, without proper control, these ever-
longer sequences can be preferentially amplified and eventually dom-
inate the library composition (Tolle et al., 2014).
Since the generation of PCR by-products are presumably created by
the base pairing combination between primers and random segments of
library sequences, the formation of these products seems to be un-
avoidable considering the vast variety of random sequences in SELEX
library. To test the rationale of eliminating parasitic PCR products by
the commonly used method of reducing PCR cycles as demonstrated in
Fig. 11A, we concentrated PCR products produced with the optimal
cycle number. After separating the concentrated products via high-re-
solution PAGE, clear PCR by-product bands could be detected
(Fig. 11B). Similarly, by choosing a more sensitive dye or incubating for
a prolonged staining time, non-specific bands could be observed from a
gel that did not initially show non-specific bands. This observation
suggests that the lack of observed PCR by-products in conventional
preparative PCR (with the determined optimal PCR cycle) is only be-
cause of the low sensitivity of detection.
Although reducing PCR cycle number can decrease the creation of
PCR by-products and PCR bias to a lower level, the amount of PCR
products required for individual rounds of SELEX is fixed (0.2 nmol for
example), which means more PCR volumes have to be prepared.
However, increasing PCR volume proportionally increases the amount
of PCR by-product, which not only counteracts the aim of the tradi-
tional analytical PCR, but also increases the cost of PCR and subsequent
ssDNA preparation or RNA transcription. Consequently, as applied in
some recent SELEX protocols, we suggest the criteria for optimal cycle
number of preparative PCR should be defined by the cycle number at
which the most PCR products corresponding to the expected position is
created (measured by either gel imaging or real-time PCR) without
considering the presence of PCR by-products (Ruff et al., 2012; Damase
et al., 2018).
5. Four common techniques for ssDNA preparation
Although developing DNA aptamers does not require the reverse
transcription and transcription steps as RNA aptamers do, the ssDNA
preparation procedure associated with DNA aptamer selection makes it
not as easy as one would expect. Indeed, except for the single round-
selection protocol, generation of high quality ssDNA from double-
stranded PCR products is of paramount importance for successful DNA
aptamer development (Svobodova et al., 2012). With more and more
DNA aptamers being developed in recent years, the question of how to
create high quality ssDNA has been comprehensively studied (Table 2).
To develop the first DNA aptamer back in 1992, ssDNAs were pre-
pared by Ellington and colleagues via an asymmetric PCR amplification
method (Ellington and Szostak, 1992). The asymmetric PCR is designed
Fig. 11. The commonly used protocol to determine
optimal PCR cycle is problematic. (A) The optimized
PCR cycles for library amplification is commonly
defined by the cycle number at which the most PCR
products is created, while no PCR by-product was
detected. In this case, cycle 10 is selected to prepare
amplification PCR for next round of SELEX; (B) PCR
product from cycle 10 was concentrated 10 times
and separated on a 12% PAGE gel with the original
cycle 10 PCR product as control. Clear PCR parasite
bands were detected in the concentrated group,
which means the undetected PCR by-product bands
on the original PCR products is because of the low
sensitivity of detection.
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to preferentially amplify one strand of the parental DNA more than the
other by adding an unequal molar ratio of forward and reverse primers.
As asymmetric PCR proceeds, the primer with higher concentration can
synthesize an excess of ssDNA in each cycle. Theoretically, this is a
quite straightforward ssDNA preparation strategy. However, it should
be noted that the eventual PCR products comprise not only single but
also double stranded DNA as well as free primer sequences. Therefore,
the PCR products have to be separated by non-denaturing PAGE gel to
separate the different molecular weights of dsDNA, ssDNA and primers,
followed by an elution step to extract the expected ssDNA from the gel
(Ellington and Szostak, 1992). This extra step, especially the traditional
crush-and-soak method used in gel elution of ssDNA, makes the asym-
metric PCR method not only time-consuming, but also low efficient
with massive loss of sequence information (Marimuthu Citartan et al.,
2012). What’s more, apart from the requirement to adjust the optimum
primer ratios from case to case, the native gel used in this procedure
adds extra concern for high quality ssDNA preparation. Although the
resolution of PAGE gel with a concentration of 10-15% is high enough
to separate oligonucleotide as short as 10 nt, upon loading of the
asymmetric PCR product onto the native gel, unlike the dsDNAs and the
homogeneous primers which display sharp bands, the position of ssDNA
sequences would very likely to be smeary (Wittig and Schagger, 2005).
This is caused by the heterogeneous nature of the ssDNA pool. The
different intramolecular interactions such as Watson-Crick base-pair-
ings, mismatches, non-Watson-Crick base-pairings, bulges, and loops
between different sequence species inevitably result in different struc-
tural conformations (Fernandez-Millan et al., 2017). Different to de-
naturing gel, where the mobility of all sequences was strictly de-
termined by the molecular weight of the particular sequence, in a
native gel as used in asymmetric PCR, the mobility of sequences is af-
fected also by other properties of sequences such as electrical charge
and tertiary structures. As a result, the accurate separation of the ex-
pected ssDNA from native gel could be difficult.
Although having various limitations, asymmetric PCR method had
been successfully used for developing some of the early DNA aptamers.
Since then, various ssDNA preparation techniques have been explored,
including denaturing urea-polyacrylamide gel (Wu et al., 2018),
lambda exonuclease digestion (Pfeiffer et al., 2018) and magnetic se-
paration with streptavidin-coated beads (Shigdar et al., 2013b). Among
them, alkaline denaturation of biotinylated PCR products attached to
streptavidin-coated magnetic beads is by far the most wildly used
strategy (Svobodova et al., 2012). Briefly, during PCR, the primer
corresponding to the undesirable sequence is biotinylated, then the
biotinylated PCR product is immobilized onto streptavidin beads. After
a step of alkaline denaturation, the desired non-biotinylated ssDNA is
able to be separated from the biotinylated strand/streptavidin beads
and eluted into solution. Aided by the magnetic beads, the whole pro-
cedure of this method is very straightforward and typically the process
takes only 20 minutes. However, problems associated with this method
have been reported recently by various groups. Firstly, during the al-
kaline treatment, Paul and colleagues observed the dissociation of
streptavidin from beads (Paul et al., 2009), which results in the un-
desired biotinylated strands entering into the elution and detrimentally
affecting the quality of the prepared ssDNA pool by re-annealing to the
complementary strands. Furthermore, the presence of streptavidin in
the aptamer pool provides an extra target during the SELEX process.
Indeed, unexpected obtaining of streptavidin-targeted aptamers have
been repeatedly reported when such protocols were applied ((Tahiri-
Alaoui et al., 2002). The trend of accumulating PCR by-products pre-
sents another challenge for the application of this method. As described
previously (Tolle et al., 2014), the prolonged PCR by-products, either
ladder or non-ladder type, contain more than one biotin conjugated
primer sequences. Since the binding of PCR products to streptavidin
beads is determined by its biotin portion, with more biotin molecules,
streptavidin beads show stronger binding preference to PCR by-pro-
ducts than normal PCR products. Moreover, the long stretches of such
by-products allow for more efficient annealing during PCR (Tolle et al.,
2014), without an effective procedure to remove them from the reac-
tion, they could accumulate with the progression of SELEX and even-
tually dominate the PCR products. This problem of accumulating PCR
by-products is reflected by the well-recorded phenomenon that the
optimal PCR cycle number (determined by maximum cycle without
showing PCR by-products) reduces with the progression of SELEX when
such a method was used, with typically 12-14 cycles for early rounds
Table 2
Current strategies for ssDNA separation.
Methods Advantages Disadvantages Comments
Asymmetric PCR •Lower cost (Svobodova et al., 2012) •Complex steps of native gel separation and gel
elution of ssDNA are required (Svobodova et al.,
2012)
•Time-consuming, low efficient with massive loss of
sequence information (Marimuthu Citartan, 2012)
•Preferentially amplify one strand of the





•Time saving, the whole process
takes around 20 min (Shigdar et al.,
2013b)
•Dissociation of streptavidin from beads results in
pool quality of ssDNA and introduces extra SELEX
target (Svobodova et al., 2012)
•Tend to accumulate PCR by-products and result in
SELEX fail (Shigdar et al., 2013b)
•Extra cost required to purify PCR product (Paul
et al., 2009)
•The most used Strategy
•Biotiylation of the primer corresponding to the
undesirable sequence to facilitate streptavidin
-based separation
Lambda exonuclease digestion •Easy to perform (Svobodova et al.,
2012)
•Extra step to eliminate
exonuclease could compromise the simplicity and
yield of this method (Pfeiffer et al., 2018)
•Insufficient enzymatic reaction results in pool
ssDNA quality (Bergallo et al., 2006)
•Tend to accumulate PCR
by-products and result in SELEX fail (Svobodova
et al., 2012)
•Introducing 5´phosphate
group into the primer
corresponding to the
unwanted DNA strand to
allow exonuclease digestion
•Extra care required to
control the creation of PCR by-product
Denaturing Urea-PAGE gel
separation
•Better quality of ssDNA (Svobodova
et al., 2012)
• High separation resolution
(Rahimizadeh et al., 2017)
•PCR products can be directly loaded
into gel (Svobodova et al., 2012)
•Minimal accumulation of PCR by-
products (Rahimizadeh et al., 2017)
•With traditional crush-and-soak method, recovering
ssDNA from gel is time-consuming (Svobodova et al.,
2012)
•Adding poly-nucleotide to one primer to result
in the two strands of the PCR products with
different lengths
•By employing electro-
elution, the whole process could be simplified
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dropping to 6-8 cycles for rounds afterwards (Shigdar et al., 2013b).
Furthermore, since any biotin-labelled sequences could equally bind the
streptavidin-labelled magnetic beads, before performing ssDNA se-
paration, one needs to remove the biotin-conjugated free primers and
primer dimers in advance via devices such as PCR product cleaning
columns, which not only increase SELEX cost, but also increases the
possibility of losing potential aptamer candidates.
An alternative method to streptavidin bead-based ssDNA separation
is the lambda exonuclease digestion of undesired strands (Pfeiffer et al.,
2018). Lambda exonuclease is a highly processive exodeoxyr-
ibonuclease that selectively digests the 5´-phosphorylated strand of
dsDNA. By introducing 5´-phosphate group into the primer corre-
sponding to the unwanted DNA strand, after the PCR reaction, this
phosphorylated strand can be removed by lambda exonuclease diges-
tion. Nevertheless, although this technique looks appealing, it is not
commonly used. This is partly because the extra step of eliminating
exonuclease to prevent the presence of additional target via phenol/
chloroform extraction and subsequent ethanol precipitation could sig-
nificantly compromise the simplicity and yield of this method. As re-
ported, the phenol/chloroform extraction itself could result in loss of
30% nucleic acid sequences (Bergallo et al., 2006). In addition, the
application of this method is also challenged by the high costs of
lambda exonuclease and the inconsistent ssDNA quality caused by in-
sufficient enzymatic processes (Svobodova et al., 2012). Furthermore,
because all sequences without 5’ phosphorylation will be collected in
the harvest ssDNA pool, a stringent preparative PCR is required to
control the creation of PCR by-products (in which the 5’ phosphate
could absence on both strands or present randomly on any strand) and
provides only one defined length of dsDNA (Avci-Adali et al., 2010).
However, as discussed in the section of 4.3, as an intrinsic feature of
amplifying high diversity template pools, the PCR by-products is in-
evitable.
The denaturing urea-polyacrylamide gel-based ssDNA separation is
another commonly used ssDNA preparation method (Wu et al., 2018).
With this method, PCR is performed with a primer that contains a
spacer as terminator (e.g., hexaethylene glycol) and an extension of
nucleotides (e.g., poly 20A) to result in the two strands of the PCR
products with different lengths. After PCR, the two strands of the am-
plicon are separated by denaturing gel electrophoresis. The gel block
containing the desired ssDNA is then collected and the ssDNAs are
extracted. Differing from the asymmetric PCR method where a native
PAGE gel is employed, the different strand length of the PCR products
in this method allows the utilization of a denaturing gel. Theoretically,
under a denature condition, all of the components of the PCR product
(including primers, unwanted long sequence containing extra oligonu-
cleotides, expected ssDNA sequence, PCR by-product sequence) will all
present in single strand forms and the mobility of them will be decided
strictly by the molecular weight of individual sequences. This method
therefore not only ensures an accurate separation of high-quality ssDNA
by a visible manner, but also allows researchers to remove PCR by-
products after each round of SELEX, eliminating the accumulation of
PCR by-products with the progress of SELEX. The PCR by-products are
normally undetectable even after 14 cycles of PCR in later stages of
SELEX (Round 10 -12 for example) (Rahimizadeh et al., 2017). Another
feature of this method, making it attractive, is that it allows the direct
loading of raw PCR products into gels, thus minimizing the loss of
ssDNA sequences. In contrast, as discussed previously, for both the
lambda exonuclease digestion and magnetic beads-based ssDNA se-
paration, a pre-treatment of the PCR products is required. Without the
requirement of fancy equipment, and with various advantages, the
traditional denaturing urea-polyacrylamide gel-based ssDNA separation
is, however, very time consuming (Svobodova et al., 2012). Similar to
the procedure used in the asymmetric PCR method, the classical crush-
and-soak method requires up to 12 hours of incubation time to elute
ssDNA from the collected gel blocks. Recently, this problem was solved
by applying electro-elution via designer dialysis tubes. As reported by
an electro-elution protocol, the whole elution time could be dramati-
cally minimized to as short as 30 min (Rahimizadeh et al., 2017).
6. Enhancing drug-like property of aptamers by Post SELEX
modification
Similar with its antibody counterpart, aptamers hold great potential
for therapeutic or diagnostic applications. After the binding to their
targets, aptamers could serve as either an agonist or an antagonist de-
pending on the intrinsic activity (Mayes et al., 2018). From the per-
spective of drug development, aptamers do have certain advantages
over antibodies, such as low/no immunogenicity, prolonged shelf life,
ease of quality control and importantly, the reversible pharmacology
effects via complimentary oligonucleotides (Muller et al., 2008). Even
so, to qualify as a drug for clinical applications, apart from sufficient
targeting capacity and specificity (main concerns during SELEX pro-
cess), an aptamer also needs to meet other requirements such as re-
duced produce cost, enhanced serum stability, and sufficient bioavail-
ability. Fortunately, aptamers are developed and synthesized in vitro,
endowing them with great flexibility to incorporate various chemical
modifications for further improving drug-like properties without com-
promising on aptamer binding specificity and affinity.
6.1. Obtain short aptamer sequences via truncation and site-directed
mutagenesis
Aptamers developed by the SELEX process are normally 60-100 nt in
length containing a randomized region of 25–50 nt and fixed primer
binding region at each terminus (Chen et al., 2017). As discussed in
Section 2.2.1.1, fixed primer binding sequences generally do not con-
tribute to the binding properties of aptamers. For this reason, during
sequence data analysis, the primer binding sites are normally deleted,
leaving only the random region for binding studies. The randomized
sequence region of the aptamer could be further shortened by structural
analysis of the developed aptamers. As reported, the binding property
of an aptamer to its target is contributed mainly by more complex and
information-rich structures such as the G-quadruplexes, three/five-way
junctions, and hairpin structure (Luo et al., 2010; Tucker et al., 2012).
Based on this knowledge, and facilitated by various multiple alignment
and structural simulation software such as ClustalW, Mfold, and RNA-
fold, an existing aptamer can be further shortened by selectively
choosing motifs likely to specifically bind to the target. Indeed, in many
cases, the truncated shorter sequences do keep the same or even better
binding affinity and target specificity when compared with the parent
aptamer sequences (Gao et al., 2016b; Nadal et al., 2013; Sung et al.,
2014). Site-directed mutagenesis represents a more accurate method to
identify the binding motif of a given aptamer and obtain the shortest
possible aptamer sequences (Zheng et al., 2015). For this purpose,
based on secondary structure prediction, an existing aptamer needs to
be truncated and point mutated to create a series of structural deriva-
tives. After comprehensively exploring the relationship between in-
dividual truncated sequence and function of the aptamer via binding/
biological functional assessment, the minimal required sequence for its
binding activity could be identified (Cho and Lee, 2009; Zheng et al.,
2015). For example, by introducing modifications in different positions
of a thrombin aptamer, and accompanied by functional evaluation, the
functional motif of this aptamer to thrombin target was identified
(Avino et al., 2012). In addition, similar to previously mentioned error-
prone PCR (Section 4.1) and the aptamer affinity maturation techniques
(Section 2.3.2.2), this method also provides an option to further im-
prove the binding property of an existing aptamer.
6.2. The stability of aptamers can be further improved by chemical
modifications
To introduce aptamers as recognition/detection elements for in vivo
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applications, the serum stability of aptamer is a major concern. In ad-
dition to the introduction of various chemical modifications or non-
natural nucleotide analogues to improve the stability of library pools
during the SELEX process, such modifications can also be introduced
into an already selected aptamer. However, limited by the current
technologies to predict the 3D structures of nucleic acids, the effect of
introduced chemical modifications on the conformation of aptamers is
difficult to predict. As a result, the post-SELEX chemical modification is
generally conducted by stepwise exchange of individual bases and
subsequent experimental testing. Many post-SELEX chemically mod-
ified serum-resistant aptamers have been reported during the past years
including 2'-O-methyl, 2'-Fluoro, and LNA (Ni et al., 2017).
6.3. Improve the binding property of selected aptamers
Surprisingly, in many cases, improving nuclease resistance of ap-
tamers by some chemical modification such as 2'-O-methyl also im-
proves the binding affinity of the aptamers (Tucker et al., 1999). The
increased binding property presumably comes from the higher thermal
stability of the tertiary structure (Vater and Klussmann, 2015). Dif-
ferent from its antibody counterpart which generally displays stable
structures in different incubation conditions, the change of incubation
condition can dramatically reduce or even eliminate the binding affi-
nity of aptamers. This is because the conformation of a given aptamer is
affected heavily by various factors such as temperature, pH, type and
concentration of cations. For example, the well characterized thrombin
binding aptamer (TBA15) developed by Bock L.C. et al. was found only
folding into its functional conformation in the presence of K+ (Avino
et al., 2012). Similarly, aptamers developed in PBS could display no
binding property in an in vivo setting in serum. We firmly believe that
systematic investigations to improve the thermal stability of aptamers
could greatly contribute to future aptamer related applications, and
progress in nucleic acid chemistry could play an important role in this
aspect.
The previously mentioned error-prone PCR (Section 4.1), aptamer
affinity maturation technique (Section 2.3.2.2) and site-directed mu-
tagenesis can also be exploited to improve the binding affinity of ap-
tamers. In a recent study, Nonaka and colleagues designed a series of
mutated versions of a VEGF-binding DNA aptamer by site-directed
mutagenesis using a genetic algorithm and a secondary structure pre-
diction program (Nonaka et al., 2013). Eventually, four new aptamers
with binding affinity 16-fold higher than that of the original aptamer
were obtained. In another site-mutagenesis study, Bullock et al found
the binding affinity of a selected aptamers could be improved by up to
30-fold (Bullock et al., 2000). The construction of bivalent or multi-
valent aptamers is a relatively straightforward strategy to improve the
binding sensitivity and biological function of existing aptamers. Im-
portantly, to develop polyvalent aptamers, one can use the same ap-
tamer or use a combination of different aptamers (Vorobyeva et al.,
2016; Hughes et al., 2017). Therefore, a synergistic effect of combined
use of different aptamers could be achieved. For example, Mayer and
colleagues designed a bivalent aptamer by using two aptamers targeting
the different positions of the thrombin molecule. The resulting bivalent
aptamer gave a 16.6-fold better inhibition efficiency than the binding of
the monovalent ligand (Muller et al., 2008). However, it was observed
that the activity of multivalent aptamers is not proportional to the
number of monomers. Thus, the most suitable subunit number and
linker type must be experimentally tested when constructing such
structures (Musumeci and Montesarchio, 2012).
6.4. Modification for sufficient bioavailability
A typical 25 to 40 nt aptamer has a molecular weight of about
8,250–13,200 Da. Due to its small size, after systemic administration,
aptamers are rapidly excreted from circulation in minutes via renal
clearance. Therefore, after obtaining a serum resistant aptamer, the
plasma half-life and bioavailability of the aptamer in clinical setting is
governed by the rate of kidney clearance. The threshold for glomerular
filtration is around 10 nm, theoretically, particles with diameter larger
than this threshold would avoid the rapid renal clearance and display
prolonged circulation time (Wang et al., 2015). Therefore, the clearance
rate of an aptamer could be decreased by increasing its molecular size
using site-specific addition of various substances such as polyethylene
glycol (PEG), lipids (Ni et al., 2017) or by attaching aptamers to the
surface of nanoparticles (Jo and Ban, 2016). Among them, the PEGy-
lation (attaching aptamer with different molecular weight of poly-
ethylene glycol) is the most widely used strategy. In fact, this method
has been used in some of the clinically tested aptamer drugs entered in
clinical trials including the FDA approved aptamer drug Macugen. By
attaching a 40 kD PEG, Macugen showed plasma half-life of 9.3h suf-
ficient for most clinical purposes (Drolet et al., 2000).
Obviously, by increasing molecule size, bivalent or multivalent
aptamers not only potentially increase the binding property of apta-
mers, they also show an advantage in terms of bioavailability
(Vorobyeva et al., 2016). In short, by combined use of a polyvalent
aptamer and hydrophobic groups such as PEG, the drug-like property of
the aptamer could be greatly improved. In a previous study, by at-
taching PEG to a multivalent aptamer consists of four mIgM targeting
aptamers, Mallikaratchy and colleagues obtained a chimeric aptamer
structure with a particle diameter higher than 25.2 nm, well above the
10 nm threshold of glomerular filtration. As a result, this chimeric
structure displayed enhanced binding specificity and desirable phar-
macological properties suitable for biomedical applications
(Mallikaratchy et al., 2011). To translate aptamers from bench to
bedside, the post-SELEX modification is unavoidable. However, Post-
SELEX optimization remains a challenging process, due to the incap-
ability to accurately predict the effect of various modifications on the
tertiary structure of aptamers. To obtain an aptamer with improved
drug-like features such as enhanced affinity, serum stability, and
bioavailability, a trial-and-error process is imperative. However, post-
SELEX modification does provide an opportunity for aptamer-based
drug development.
7. Conclusion
Aptamers are nucleic acid analogue of traditional antibodies and
possess various advantages for theranostic purposes. Considering the
importance of antibodies in various biomedical applications, especially
the current enthusiasm in immuno-oncology therapy associated
monoclonal antibodies (such as anti-PD-1/PD-L1 antibody) develop-
ment (Ventola, 2017), aptamer technology holds great potential to
become a new source of lead compounds and play important role in the
future biomedical field. However, the lack of high performing aptamers
is still a major obstacle for aptamer-based research and translational
applications (Zhuo et al., 2017). Fortunately, SELEX is a very conserved
process. Despite more than 32 SELEX variations have been reported
during the past decades (Darmostuk et al., 2015), only a few selection
approaches diverge from the core methodology of the traditional SELEX
(Szeto et al., 2013). During the past three decades, with developments
in material sciences and analytical techniques, dramatic improvement
have made in the key steps of SELEX such as initial library design (e.g.
chemical modifications, novel nucleic acids and computer-based library
design and bioinformatics), target preparation (e.g. Cell-SELEX), li-
brary/target co-incubation (e.g. Capture-SELEX), and PCR amplifica-
tion (e.g. Emulsion PCR). Researchers nowadays are facing an ever-
growing toolkit for aptamer development and new technologies are
continuing to improve selection efficiencies and reduce the efforts
needed to obtain new aptamers.
Being a comprehensive procedure consisting defined iterative pro-
cedures to deal with a wide variety of targets, it should be noted that no
single SELEX protocol is suitable for all applications. By carefully
studying each of the particular cases, choosing proper techniques for
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individual steps of SELEX, and accompanied by rational post-SELEX
strategies, we believe that personalized SELEX protocols based on deep
understanding of key steps of SELEX will facilitate researchers to ad-
dress many of the obstacles faced by current aptamer development.
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